Krystal Biotech, Inc. (KRYS)
261.80
-0.87
(-0.33%)
USD |
NASDAQ |
Feb 20, 16:00
261.90
+0.10
(+0.04%)
Pre-Market: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 7.592B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 43.36% |
| Valuation | |
| PE Ratio | 38.25 |
| PE Ratio (Forward) | |
| PS Ratio | 20.13 |
| Price to Book Value | 6.225 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.0077 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 53.42% |
Profile
| Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA. |
| URL | http://www.krystalbio.com |
| Investor Relations URL | https://ir.krystalbio.com/ |
| HQ State/Province | Pennsylvania |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | May. 04, 2026 (est.) |
| Last Earnings Release | Feb. 17, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA. |
| URL | http://www.krystalbio.com |
| Investor Relations URL | https://ir.krystalbio.com/ |
| HQ State/Province | Pennsylvania |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | May. 04, 2026 (est.) |
| Last Earnings Release | Feb. 17, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |